Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Sonia Mehta, Jodie McBride, Mathieu Uzzan, Milan Lukáš, Mathurin Fumery, Akira Nogami, Taku Kobayashi, Stephane Nancey, Joana Camões Neves, João Martins Mendes, Birte-Antina Wegener, Emilie Bergereau, Rita Fernandes, Anish John Kuriakose Kuzhiyanjal, Sophie Vieujean, Ashley Spencer, Samantha Baillie, Maria Manuel Estevinho, Inês Simão, Catarina O’Neill, Madalina Gututui, Ellen Thompson, Amina Jama, Ningyu Chai, Polychronis Pavlidis, Ferdinando D'Amico, Jimmy Limdi, Fernando Magro, Shaji Sebastian, Jonathan Digby-Bell, Gareth C. Parkes, Shahida Din, Ailsa Hart, Laurent Peyrin-Biroulet, JAKne International Study Group
{"title":"Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease – an international, multicenter, retrospective cohort study","authors":"Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Sonia Mehta, Jodie McBride, Mathieu Uzzan, Milan Lukáš, Mathurin Fumery, Akira Nogami, Taku Kobayashi, Stephane Nancey, Joana Camões Neves, João Martins Mendes, Birte-Antina Wegener, Emilie Bergereau, Rita Fernandes, Anish John Kuriakose Kuzhiyanjal, Sophie Vieujean, Ashley Spencer, Samantha Baillie, Maria Manuel Estevinho, Inês Simão, Catarina O’Neill, Madalina Gututui, Ellen Thompson, Amina Jama, Ningyu Chai, Polychronis Pavlidis, Ferdinando D'Amico, Jimmy Limdi, Fernando Magro, Shaji Sebastian, Jonathan Digby-Bell, Gareth C. Parkes, Shahida Din, Ailsa Hart, Laurent Peyrin-Biroulet, JAKne International Study Group","doi":"10.1016/j.cgh.2025.04.031","DOIUrl":null,"url":null,"abstract":"JAK inhibitor-associated acne is a common but poorly understood adverse event. This study aimed to investigate the epidemiology, clinical characteristics, and treatment outcomes of this condition in patients with inflammatory bowel disease (IBD).","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":"42 1","pages":""},"PeriodicalIF":12.0000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cgh.2025.04.031","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
JAK inhibitor-associated acne is a common but poorly understood adverse event. This study aimed to investigate the epidemiology, clinical characteristics, and treatment outcomes of this condition in patients with inflammatory bowel disease (IBD).
期刊介绍:
Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion.
As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.